It's Time to Shine a Light on Immune Status
Millions suffer from complex chronic diseases without clear and actionable diagnoses
BeaconDx introduces our breakthrough diagnostic platform MENSA:
The snapshot of your immune system
The Limits of Today's
Diagnostic Tools
Standard Serology
Detects past exposure to a virus but cannot confirm if the virus is currently active or reactivating
PCR Testing
Can detect active infection but often misses low-level or intermittent viral reactivation, especially outside acute illness
Inflammation Markers
Show general immune activation but don't identify specific cause
While helpful, current tests struggle to pinpoint active viral persistence or reactivation (like EBV, CMV, HSV) that can drive ongoing Long COVID symptoms This leaves physicians and patients searching for answers
See Your Immune Response,
Right Now
Our proprietary MENSA technology isolates active antibody-secreting cells from a standard blood draw. By measuring the antibodies these cells produce in real-time, we provide a unique snapshot of the immune system, potentially identifying actionable treatment options
Scientific Insight: B cells are crucial immune cells that produce antibodies to fight pathogens. When activated by a pathogen, some B cells differentiate into antibody-secreting cells (ASCs). MENSA specifically captures these ASCs from blood, analyzing what they're actively producing—providing a real-time view of what pathogens your immune system is currently battling
*Research Use Only (RUO)
Standard Serology Today
Detects Historical Antibodies
(Past exposure, not current activity)
BeaconDx MENSA Platform
Measures Newly Synthesized Antibodies
(Current Active Immune Response)
Driven by Science, Rooted in Purpose
20+ years of experience in precision medicine, clinical diagnostics, and entrepreneurial leadership. Previously at Abbott Labs, Danaher Business Systems (Leica Microsystems), and Natera Global Business Development
Tenured professor at Emory University and Director of the Asthma, Allergy, Immunology Program. 20+ years of expertise in human plasma cell biology and co-developer of the MENSA technology platform
Biomedical scientist specializing in immunoassay diagnostics and infectious disease research, with over a decade of experience at MicroBplex and Emory University
15+ years of experience in orthoclinical diagnostics (famously commercialized “Hot Start”). Co-developer on the MENSA technology platform
Tenured professor with 28+ years of experience as Division Chief of Rheumatology. Director of the Lowance Center for Human Immunology at Emory University
Innovation and Automation of MENSA testing
33 years of investment banking experience. Managing Director and Head of Equity Capital Markets, Americas JP Morgan
Are you looking for answers?
Finding Answers is a short documentary chronicling Dr. Schlicher's and Dr. Lee's journey as patient, physician and pioneers navigating the invisible complexities of chronic illness
It’s a deeply personal look at what happens when the medical system can’t explain what you’re going through and what it takes to fight for clarity, care, and change
Supported by Research
BeaconDx MENSA technology is supported by partnerships and funding including: the NIH Long-COVID RECOVER program, major hospital systems, top universities and non-profits like PolyBio Research Foundation
On the path to illuminating immune health for millions of people
The BeaconDx MENSA Long-COVID test is currently available for Research Use Only (RUO) as we advance towards broader clinical launch (LDT).
We are actively seeking partners to accelerate our mission. Connect with us if you are:
For Clinicians & Researchers
